These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31396944)

  • 21. Efficacy and Safety of Cream Containing Climbazole/Piroctone Olamine for Facial Seborrheic Dermatitis: A Single-Center, Open-Label Split-Face Clinical Study.
    Youn HJ; Kim SY; Park M; Jung WH; Lee YW; Choe YB; Ahn KJ
    Ann Dermatol; 2016 Dec; 28(6):733-739. PubMed ID: 27904273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seborrheic dermatitis: topical therapeutics and formulation design.
    Mangion SE; Mackenzie L; Roberts MS; Holmes AM
    Eur J Pharm Biopharm; 2023 Apr; 185():148-164. PubMed ID: 36842718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of a low molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis final report.
    Schlesinger T; Rowland Powell C
    J Clin Aesthet Dermatol; 2014 May; 7(5):15-8. PubMed ID: 24847403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
    Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
    J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of traditional Chinese medicine preparations for facial seborrheic dermatitis: case reports.
    Zhang R; Nie Y; Wang Y; Zhai X; Zhu J; Duan Y
    Heliyon; 2022 Dec; 8(12):e12338. PubMed ID: 36582725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Seborrheic dermatitis in clinical practice].
    Rovelli F; Mercuri SR; Naldi L
    Recenti Prog Med; 2011 Mar; 102(3):126-33. PubMed ID: 21572485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.
    Diehl C; Ferrari A
    J Drugs Dermatol; 2013 Mar; 12(3):312-5. PubMed ID: 23545914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of a low-molecular weight hyaluronic Acid topical gel in the treatment of facial seborrheic dermatitis.
    Schlesinger T; Rowland Powell C
    J Clin Aesthet Dermatol; 2012 Oct; 5(10):20-3. PubMed ID: 23125886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seborrheic dermatitis: an overview.
    Schwartz RA; Janusz CA; Janniger CK
    Am Fam Physician; 2006 Jul; 74(1):125-30. PubMed ID: 16848386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seborrheic dermatitis.
    Sampaio AL; Mameri AC; Vargas TJ; Ramos-e-Silva M; Nunes AP; Carneiro SC
    An Bras Dermatol; 2011; 86(6):1061-71; quiz 1072-4. PubMed ID: 22281892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of seborrheic dermatitis and pityriasis versicolor.
    Faergemann J
    Am J Clin Dermatol; 2000; 1(2):75-80. PubMed ID: 11702314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy.
    Cook BA; Warshaw EM
    Am J Clin Dermatol; 2009; 10(2):103-18. PubMed ID: 19222250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluconazole and its place in the treatment of seborrheic dermatitis--new therapeutic possibilities.
    Zisova LG
    Folia Med (Plovdiv); 2006; 48(1):39-45. PubMed ID: 16918053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seborrheic dermatitis of the scalp: etiology and treatment.
    Gupta AK; Nicol KA
    J Drugs Dermatol; 2004; 3(2):155-8. PubMed ID: 15098970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lithium gluconate 8% in the treatment of seborrheic dermatitis].
    Dréno B; Blouin E; Moyse D
    Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):347-51. PubMed ID: 17483754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciclopirox gel for seborrheic dermatitis of the scalp.
    Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
    Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis.
    Starova A; Aly R
    Expert Opin Drug Saf; 2005 Mar; 4(2):235-9. PubMed ID: 15794716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review.
    Kastarinen H; Okokon EO; Verbeek JH
    JAMA Dermatol; 2015 Feb; 151(2):221-2. PubMed ID: 25629391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies.
    Dessinioti C; Katsambas A
    Clin Dermatol; 2013; 31(4):343-351. PubMed ID: 23806151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.